Albert W. Brzeczko, VP Technical Affairs - APT at ACURA PHARMACEUTICALS, INC (ACUR), bought 300,000 shares at $0.10 ($30K) on 2017-12-14, disclosed to the SEC on 2017-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ACUR | BUY | 2013-11-26 | $2K | — | Filing → |
| ACUR | BUY | 2012-05-18 | $3K | — | Filing → |